CiRC Biosciences
IL - ChicagoBiotechnology
Focus: CiRC Biosciences is a private biotechnology company focused on cell therapy via ex-vivo small molecule treatment, positioned at the intersection of gene therapy and cell therapy innovation. The company operates as a pre-revenue biotech with limited public disclosure on scale.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
1
Should You Work at CiRC Biosciences?
AI assessmentCiRC Biosciences represents a high-risk, high-reward early-stage play best suited for career professionals seeking frontier science exposure over near-term stability.
Why Work Here
- Early-stage opportunity in high-growth therapeutic areas (gene therapy, cell therapy) with potential for significant scientific impact and equity upside
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Open Roles: 1 active job
Help build intelligence for CiRC Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.